This Ivermectin News could change EVERYTHING for fighting cancer

A groundbreaking new human study on ivermectin and fenbendazole has revealed that 84.4% of cancer patients experienced clinical benefit after six months of treatment—nearly half saw tumors disappear or shrink dramatically. This is the largest real-world study of its kind, and it’s now challenging the entrenched cancer treatment paradigm dominated by chemotherapy, radiation, and expensive biopharmaceuticals. The guest, epidemiologist Nicholas Holscher, claims the CIA classified a Soviet-era study from the 1950s showing antiparasitics had anti-tumor effects—suppressing this knowledge for decades to protect a multi-billion-dollar cancer treatment industry. Ivermectin and fenbendazole, long dismissed as 'horse paste,' are now shown to target cancer stem cells, disrupt glucose metabolism in tumors, and inhibit cell division through microtubule disruption—12 distinct anti-cancer mechanisms in total. Despite minimal side effects and a cost of just a few thousand dollars per year (vs. over $100,000 for chemo), the medical establishment has ignored this data. The study’s authors are now calling for urgent, government-funded, double-blind clinical trials—free from pharmaceutical bias—to validate these findings and potentially save millions of lives. The episode also exposes a shocking environmental hazard: most high-end waterproof jackets are coated with toxic PFAS 'forever chemicals' that poison the body while repelling rain.